AAAAAA

   
Results: 1-18 |
Results: 18
Influence of maternal antibodies on neonatal immunization against respiratory viruses
Authors: Crowe, JE
Citation: Je. Crowe, Influence of maternal antibodies on neonatal immunization against respiratory viruses, CLIN INF D, 33(10), 2001, pp. 1720-1727
Blood donor leukocyte reduction filters as a source of human B lymphocytes
Authors: Weitkamp, JH Crowe, JE
Citation: Jh. Weitkamp et Je. Crowe, Blood donor leukocyte reduction filters as a source of human B lymphocytes, BIOTECHNIQU, 31(3), 2001, pp. 464
Respiratory syncytial virus vaccine development
Authors: Crowe, JE
Citation: Je. Crowe, Respiratory syncytial virus vaccine development, VACCINE, 20, 2001, pp. S32-S37
Genetic and structural determinants of virus neutralizing antibodies
Authors: Crowe, JE Suara, RO Brock, S Kallewaard, N House, F Weitkamp, JH
Citation: Je. Crowe et al., Genetic and structural determinants of virus neutralizing antibodies, IMMUNOL RES, 23(2-3), 2001, pp. 135-145
CD40-ligand in primate cardiac allograft and viral immunity
Authors: Pierson, RN Crowe, JE Pfeiffer, S Atkinson, J Azimzadeh, A Miller, GG
Citation: Rn. Pierson et al., CD40-ligand in primate cardiac allograft and viral immunity, IMMUNOL RES, 23(2-3), 2001, pp. 253-262
Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines
Authors: Crowe, JE Firestone, CY Murphy, BR
Citation: Je. Crowe et al., Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines, J IMMUNOL, 167(7), 2001, pp. 3910-3918
A RhoA-derived peptide inhibits syncytium formation induced by respiratorysyncytial virus and parainfluenza virus type 3
Authors: Pastey, MK Gower, TL Spearman, PW Crowe, JE Graham, BS
Citation: Mk. Pastey et al., A RhoA-derived peptide inhibits syncytium formation induced by respiratorysyncytial virus and parainfluenza virus type 3, NAT MED, 6(1), 2000, pp. 35-40
Recurrent Achromobacter xylosoxidans bacteremia associated with persistentlymph node infection in a patient with hyper-immunoglobulin M syndrome
Authors: Weitkamp, JH Tang, YW Haas, DW Midha, NK Crowe, JE
Citation: Jh. Weitkamp et al., Recurrent Achromobacter xylosoxidans bacteremia associated with persistentlymph node infection in a patient with hyper-immunoglobulin M syndrome, CLIN INF D, 31(5), 2000, pp. 1183-1187
Recurrent pneumococcal arthritis as the presenting manifestation of X-linked agammaglobulinemia
Authors: Peters, TR Brumbaugh, DE Lawton, AR Crowe, JE
Citation: Tr. Peters et al., Recurrent pneumococcal arthritis as the presenting manifestation of X-linked agammaglobulinemia, CLIN INF D, 31(5), 2000, pp. 1287-1288
Current approaches to the development of vaccines against RSV
Authors: Weitkamp, JH Crowe, JE
Citation: Jh. Weitkamp et Je. Crowe, Current approaches to the development of vaccines against RSV, MONATS KIND, 148(11), 2000, pp. 980-989
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy
Authors: Wright, PF Karron, RA Belshe, RB Thompson, J Crowe, JE Boyce, TG Halburnt, LL Reed, GW Whitehead, SS Anderson, EL Wittek, AE Casey, R Eichelberger, M Thumar, B Randolph, VB Udem, SA Chanock, RM Murphy, BR
Citation: Pf. Wright et al., Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy, J INFEC DIS, 182(5), 2000, pp. 1331-1342
The live attenuated subgroup B respiratory syncytial virus vaccine candidate RSV 2B33F is attenuated and immunogenic in chimpanzees, but exhibits partial loss of the ts phenotype following replication in vivo
Authors: Crowe, JE Randolph, V Murphy, BR
Citation: Je. Crowe et al., The live attenuated subgroup B respiratory syncytial virus vaccine candidate RSV 2B33F is attenuated and immunogenic in chimpanzees, but exhibits partial loss of the ts phenotype following replication in vivo, VIRUS RES, 59(1), 1999, pp. 13-22
Host responses to respiratory virus infection and immunization
Authors: Crowe, JE
Citation: Je. Crowe, Host responses to respiratory virus infection and immunization, CURR T MICR, 236, 1999, pp. 191-214
RhoA interacts with the fusion glycoprotein of respiratory syncytial virusand facilitates virus-induced syncytium formation
Authors: Pastey, MK Crowe, JE Graham, BS
Citation: Mk. Pastey et al., RhoA interacts with the fusion glycoprotein of respiratory syncytial virusand facilitates virus-induced syncytium formation, J VIROLOGY, 73(9), 1999, pp. 7262-7270
Human antibody responses to mature and immature forms of viral envelope inrespiratory syncytial virus infection: Significance for subunit vaccines
Authors: Sakurai, H Williamson, RA Crowe, JE Beeler, JA Poignard, P Bastidas, RB Chanock, RM Burton, DR
Citation: H. Sakurai et al., Human antibody responses to mature and immature forms of viral envelope inrespiratory syncytial virus infection: Significance for subunit vaccines, J VIROLOGY, 73(4), 1999, pp. 2956-2962
Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity
Authors: Whitehead, SS Firestone, CY Karron, RA Crowe, JE Elkins, WR Collins, PL Murphy, BR
Citation: Ss. Whitehead et al., Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity, J VIROLOGY, 73(2), 1999, pp. 871-877
Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus
Authors: Fisher, RG Crowe, JE Johnson, TR Tang, YW Graham, BS
Citation: Rg. Fisher et al., Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus, J INFEC DIS, 180(4), 1999, pp. 1324-1327
Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody Fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein
Authors: Crowe, JE Firestone, CY Crim, R Beeler, JA Coelingh, KL Barbas, CF Burton, DR Chanock, RM Murphy, BR
Citation: Je. Crowe et al., Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody Fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein, VIROLOGY, 252(2), 1998, pp. 373-375
Risultati: 1-18 |